Oxford Drug Design: Funding, Investors & Team (Sep 2026)
InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.
Oxford Drug Design has raised $4.0M across 2 funding rounds on record, the most recent an undisclosed round of $1.3M announced in Feb 2025.
That round is below the $4.7M median round size for Administrative Services companies tracked on FundedIQ over the last two years.
Oxford Drug Design Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Oxford Drug Design Funding Rounds
Oxford Drug Design raised $2.7M in a Convertible Note announced in May 2022.
2.8 years later, an undisclosed round of $1.3M was announced in Feb 2025.
Oxford Drug Design Founders and Leadership Team
No contact details are on record for this team yet.
Oxford Drug Design Funding Compared to Other Administrative Services Startups
Oxford Drug Design's latest round of $1.3M is below the median round in Administrative Services. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oxford Drug Design in Administrative Services and Oxford
Companies Similar to Oxford Drug Design
Vaso by Eco Manufacturing will create the panel for a four-bedroom house that will be built in four days.
Ello Group provides solutions for marketing engagement, employee benefits, and data and insight services.…
Zeroramp is a European HRtech and corporate software company that creates privacy-focused AI technologies,…
The Logistics Partnership specialized in management recruitment within the logistics and supply chain sectors.
Aveni is a prestigious tech company known for its expertise in Natural Language Processing for Financial…
Pyrexia Ltd offers an AI-native cloud platform that automates recruitment, onboarding, and compliance…
Connecting Excellence Group PLC (XCE) is a international executive recruitment firm that has integrated…
We want to build a better hiring future for everyone: the people finding jobs and the businesses hiring them.…
PPHA delivers affordable homes via rental and shared ownership, supporting access to housing and stronger…
EdSync provides education technology platforms that support school operations, learning, and data management.…
Serve First offers surveys for customers to provide feedback and platforms for staff to engage with.
Cornwall-based company, Cornish Tin Limited, is making progress in transforming the Great Wheal Vor Project.…
Oxford Drug Design Funding FAQs
What does Oxford Drug Design do?
InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.
How much funding has Oxford Drug Design raised?
Oxford Drug Design has raised $4.0M across 2 rounds on record. The most recent is an undisclosed round of $1.3M announced in Feb 2025.
When did Oxford Drug Design last raise funding?
Oxford Drug Design's most recent funding round on record is an undisclosed round of $1.3M, announced in Feb 2025.
Who founded Oxford Drug Design?
FundedIQ lists Graham Richards (Founder) at Oxford Drug Design.
Where is Oxford Drug Design headquartered?
Oxford Drug Design is based in Oxford, Oxfordshire, United Kingdom.
How many employees does Oxford Drug Design have?
Oxford Drug Design is in the 1-10 employee band.
How does Oxford Drug Design's funding compare to other Administrative Services startups?
Oxford Drug Design's latest round of $1.3M is below the $4.7M median round size for Administrative Services companies on FundedIQ across 1,897 tracked companies over the last two years.
About FundedIQ's Oxford Drug Design Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oxford Drug Design is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.